Kellen Scott 4
4 · Sun BioPharma, Inc. · Filed Mar 1, 2018
Insider Transaction Report
Form 4
Kellen Scott
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-02-27+25,000→ 25,000 totalExercise: $8.10From: 2018-02-27Exp: 2028-02-27→ Common Stock (25,000 underlying)